AADI Activist 13D/13G Filings - Aadi Bioscience Inc.

Real time Form 13D and 13G transaction reports:

Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
Shares are not adjusted for stock split.

"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

Goto Prev, 0, 1

Reported DateTime	Type	Company Symbol	Filed By Symbol	Shares Owned % Owned	Shares Vs. Prev Report	Filing
2021-05-26 5:01 pm Purchase	13G	AERPIO PHARMACEUTICALS INC ARPO	Point72 Asset Management L.P.	1,825,000 3.9%	1,825,000 (New Position)	View
2021-02-10 3:22 pm Sale	13G	AERPIO PHARMACEUTICALS INC ARPO	BML Investment Partners L.P.	2,109,942 4.5%	-180,289 (-7.87%)	View
2021-02-10 10:30 am Purchase	13G	AERPIO PHARMACEUTICALS INC ARPO	VANGUARD GROUP INC	2,711,579 5.76%	2,711,579 (New Position)	View
2021-01-08 9:59 pm Purchase	13G	AERPIO PHARMACEUTICALS INC ARPO	Ikarian Capital LLC	475,778 1%	475,778 (New Position)	View
2020-11-20 5:31 pm Unchanged	13D	AERPIO PHARMACEUTICALS INC ARPO	Satter Muneer A	5,621,835 11.9%	0 (Unchanged)	View
2020-11-12 5:15 pm Purchase	13D	AERPIO PHARMACEUTICALS INC ARPO	ORBIMED ADVISORS LLC	5,193,946 11%	5,193,946 (New Position)	View
2020-05-15 06:05 am Sale	13D	AERPIO PHARMACEUTICALS INC ARPO	Novartis Bioventures Ltd	635,236 1.57%	-2,512,431 (-79.82%)	View
2020-04-22 07:56 am Sale	13D	AERPIO PHARMACEUTICALS INC ARPO	Novartis Bioventures Ltd	3,147,667 7.76%	-438,173 (-12.22%)	View
2020-03-09 2:32 pm Purchase	13G	AERPIO PHARMACEUTICALS INC ARPO	BML Investment Partners L.P.	2,290,231 5.6%	2,290,231 (New Position)	View
2019-06-07 4:15 pm Sale	13D	AERPIO PHARMACEUTICALS INC ARPO	Novartis Bioventures Ltd	3,585,840 8.83%	-463,964 (-11.46%)	View

Goto Prev, 0, 1